Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 3/20 | 0.72 |
| ▸ | MAOB | P27338 | 7/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.38 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2781788 | 0.89 | VDR (0.70) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL3280657 | 0.84 | VDR (0.71) | VDR | |
| SCHEMBL3280127 | 0.83 | VDR (1.00) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL3280121 | 0.83 | VDR (1.00) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL3280131 | 0.83 | VDR (1.00) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL6155253 | 0.80 | VDR (0.47) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL6155558 | 0.80 | VDR (0.51) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL3280116 | 0.80 | VDR (0.47) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL3279973 | 0.79 | VDR (0.64) | VDRMAOBNR4A2NR4A1NR4A3 | |
| SCHEMBL6155591 | 0.79 | VDR (0.62) | VDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700657-B2 | Vitamin D analogs | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-04-20 | — | — | US | claimed |
| US-20040224929-A1 | Novel vitamin D analogs | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-11-11 | — | — | US | claimed |
| US-7700657-B2 | Vitamin D analogs | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-04-20 | — | — | US | disclosed |
| US-7700657-B2 | Vitamin D analogs | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-04-20 | — | — | US | disclosed |
| EP-1395538-B1 | VITAMIN D ANALOGUES | GALDERMA RES & DEV (FR) | 2009-12-30 | — | — | EP | disclosed |
| US-20040224929-A1 | Novel vitamin D analogs | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-11-11 | — | — | US | disclosed |
| EP-1395538-A1 | VITAMIN D ANALOGUES | Galderma Research & Development, S.N.C. (FR) | 2004-03-10 | — | — | EP | disclosed |
| WO-2002094754-A1 | VITAMIN D ANALOGUES | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2002-11-28 | — | — | WO | disclosed |